Causes and countermeasures for dizziness after taking Biken Pronol Tablets (Bituvi)
Biktarvy is a compound antiviral drug mainly used to treat HIV infection. It is composed of Bictegravir< /span>), tenofovir alafenamide fumarate (TAF) and emtricitabine (Emtricitabine). Dizziness is one of the adverse reactions occasionally reported by Biktarvy patients during treatment, which may be related to the drug's mild effect on the central nervous system, blood pressure fluctuations or electrolyte changes. Although symptoms are mild in most cases, they still require attention.
The causes of dizziness may include changes in drug blood concentrations caused by individual differences. BiktarvyThe bictevir in Biktarvy has certain central penetration and may have slight effects on the nervous system, especially during the first dose or dose adjustment period. In addition, patients taking other antihypertensive drugs, diuretics or central nervous system drugs concurrently may also increase the risk of dizziness.

Measures to deal with dizziness mainly include maintaining adequate fluid intake and avoiding sudden changes in body position to reduce the impact of blood pressure fluctuations on the central nervous system. Patients should pay attention to getting up slowly while taking the medicine and avoid driving or operating dangerous machinery to prevent falls or accidents. At the same time, regular monitoring of blood pressure and blood chemistry indicators can help detect possible drug-related risks in time.
If dizziness persists or worsens, you should contact your doctor promptly to evaluate whether it is related to Biktarvy medication. If necessary, the medication time or dosage can be adjusted. The doctor may develop an individualized treatment plan based on the patient's overall medication status, underlying diseases, and hematological indicators. Through standardized medication and lifestyle management, the dizziness symptoms of most patients can be effectively alleviated, while ensuring the continuity and efficacy of antiviral treatment.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)